Peripheral Arterial Disease

Treating the Whole Patient

An estimated 8 million Americans are affected by peripheral arterial disease, also known as peripheral artery disease (PAD). This condition can cause leg discomfort when walking or more serious problems such as pain in the foot at rest, toe ulcers, toe infections and gangrene. The Johns Hopkins multidisciplinary vascular and endovascular team is dedicated to optimizing the patient’s vascular health, not just treating arterial blockages. Our team develops a personalized treatment plan for each patient diagnosed with PAD.

Experts

A team of specialists offer a full range of peripheral arterial disease treatment options.
Patient Information

Learn about peripheral arterial disease.
Appointments and Locations

Request an appointment and view locations for care.

Schedule an Appointment: 410-955-5165

Peripheral Arterial Disease: Why Choose Johns Hopkins

Johns Hopkins experts provide the entire range of treatments for PAD, including medical management, vascular surgery, minimally invasive/endovascular therapy and hybrid therapies. Surgery is not always indicated for PAD.
Our experts are focused on providing you with the appropriate treatment(s) that meet your needs at the appropriate times.
The hybrid therapies available at Johns Hopkins are not typically available at smaller medical centers.
Our multidisciplinary team will work with you and your family from evaluation to treatment, and provide follow-up care.

We are dedicated to treating the whole patient, not just lesions.
Christopher Abularrage, vascular surgeon

Treatment Options for Peripheral Arterial Disease

Learn about treatment options for peripheral artery disease from vascular surgeon Thomas Reifsnyder, M.D.

Watch on

Our Team

Our nationally recognized vascular and endovascular surgery specialists provide complete vascular care, including noninvasive diagnostic testing methods, risk factor control, medical management, minimally invasive catheter-based endovascular balloon angioplasty and stent procedures, and traditional open bypass surgery, and also have available the newest technologies under development — which may not be available elsewhere — to treat patients. Not only are our team members experts in the management of vascular disease, but they are leaders in the development of unique hybrid/collaborative approaches and new evolving technologies to treat the most complex and difficult clinical problems.